GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (LTS:0NF3) » Definitions » Net Investment Income

Paion Ag (LTS:0NF3) Net Investment Income


View and export this data going back to 2007. Start your Free Trial

What is Paion Ag Net Investment Income?

Net Investment Income only applies to insurance companies.


Paion Ag (LTS:0NF3) Business Description

Traded in Other Exchanges
Address
Heussstrasse 25, Aachen, DEU, 52078
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.